DENVER, May 15, 2006 (BUSINESS WIRE) -- Lifeline Therapeutics, Inc. (LFLT) , maker of Protandim(R), today announced revenues of $1,390,623 and a loss of $(670,911), or $(0.03) per share, for its third fiscal quarter ended March 31, 2006. For its...
Vancouver, Canada - Forbes Medi-Tech Inc. (TSX:FMI; NASDAQ:FMTI) today announced its financial results for the three months ended March 31, 2006. Comparative period for these statements is the three months ended March 31, 2005. All amounts are in...